RPSAP39

Across TCGA pan-cancer cohorts, RPSAP39 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPSAP39 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPSAP39 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPSAP39 expression acts as an unfavorable survival marker, although some lineages such as THCA and UVM show a favorable association.

OV, THCA, and UVM are the cancer types where RPSAP39 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Quartile	II,III,IV	0.300	0.416	.014	42	view →
THCA	OS	Tertile	All	1.000	0.976	.003	40	view →
UVM	OS	Tertile	All	0.923	0.386	.004	36	view →
STAD	OS	Quartile	IV	0.258	0.770	.007	27	view →
SKCM	OS	Median	All	0.495	0.293	.003	25	view →
READ	DFS	Median	III,IV	0.647	0.193	.014	14	view →
UCS	DFS	Tertile	IV	0.874	0.296	.024	12	view →
UCEC	DFS	Tertile	All	0.791	0.875	.010	10	view →
KICH	DFS	Tertile	III,IV	0.283	0.763	.020	9	view →
CHOL	OS	Tertile	II,III,IV	1.000	0.410	.037	9	view →
LUAD	OS	Quartile	All	0.239	0.427	.007	9	view →
BLCA	OS	Tertile	All	0.795	0.595	.035	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPSAP39–OV (OS)

Open the OV breakdown →